These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 20974206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 4. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 6. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.
    Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S.
    Clin Transplant; 2012 Jun; 26(4):644-56. PubMed ID: 22432638
    [Abstract] [Full Text] [Related]

  • 9. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
    Freitas MC, Rebellato LM, Ozawa M, Nguyen A, Sasaki N, Everly M, Briley KP, Haisch CE, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Transplantation; 2013 May 15; 95(9):1113-9. PubMed ID: 23514959
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.
    Kidney Int; 2012 Sep 15; 82(5):598-604. PubMed ID: 22622504
    [Abstract] [Full Text] [Related]

  • 11. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y, Yang CW, Moon IS, Kim M, Lim J, Park YJ, Han K, Oh EJ.
    Ann Clin Lab Sci; 2010 Sep 15; 40(4):330-5. PubMed ID: 20947806
    [Abstract] [Full Text] [Related]

  • 12. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S.
    Transplantation; 2008 Jun 15; 85(11):1557-63. PubMed ID: 18551059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jun 15; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 15. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B, Kennel A, Ladrière M, Kessler M, Perrier P.
    Transpl Immunol; 2009 Jul 15; 21(3):166-8. PubMed ID: 19341797
    [Abstract] [Full Text] [Related]

  • 16. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 17. Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period.
    Iniotaki-Theodoraki AG, Boletis JN, Trigas GCh, Kalogeropoulou HG, Kostakis AG, Stavropoulos-Giokas CG.
    Transplantation; 2003 May 15; 75(9):1601-3. PubMed ID: 12792524
    [Abstract] [Full Text] [Related]

  • 18. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011 May 15; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 19. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
    Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL.
    Transpl Int; 2014 Jan 15; 27(1):60-8. PubMed ID: 24131087
    [Abstract] [Full Text] [Related]

  • 20. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S, Valente U, Nocera A.
    Clin Transplant; 2007 Jan 15; 21(1):47-56. PubMed ID: 17302591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.